Close

Welcome back to Stockhouse
Member Sign In

Email or Username:
Password:
Close

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History  |  Analysts  |  Earnings  |  Insiders

VistaGen Therapeutics Inc VSTA

Sector: Healthcare | Sub-Sector: Biotechnology

VistaGen Therapeutics Inc is a stem cell company. The Company focused on drug rescue and regenerative medicine.
Price: $8.50 | Change: $0.00 | %Change: 0.00%
Volume: 0 | Day High/Low: N/A/N/A | 52 Week High/Low: 15.00/7.99
View modes: 
0 stars

VistaGen Therapeutics, Inc. (VSTA) AV-101 Rivals Ketamine an

VistaGen Therapeutics, Inc. (VSTA) AV-101 Rivals Ketamine and Other Next-Gen Anti-depressants On the street ketamine is referred to as “Special K,” a drug popular in the party scene because of its...read more
0 stars

VistaGen Therapeutics, Inc. (VSTA) Embarking on Key Stage 2

VistaGen Therapeutics, Inc. (VSTA) Embarking on Key Stage 2 Clinical Trial of Potential Breakthrough Major Depression Therapy With the very public suicide of actor/comedian Robin Williams recently...read more
0 stars

VistaGen Therapeutics Inc. (VSTA) AV-101 Poised to Emerge as

VistaGen Therapeutics Inc. (VSTA) AV-101 Poised to Emerge as a Leading Candidate in Multibillion Dollar Global Antidepressant Market Depression affects nearly 7% of all adults in the U.S. and over...read more
0 stars

VistaGen Therapeutics, Inc. (VSTA) Authorizes Letter of Inte

VistaGen Therapeutics, Inc. (VSTA) Authorizes Letter of Intent with NIMH for NIH-Sponsored Phase 2 Study of AV-101 in Major Depressive Disorder VistaGen signed a Letter of Intent to enter into a...read more
0 stars

VistaGen Therapeutics, Inc. (VSTA) Sees AV-101 as Potential

VistaGen Therapeutics, Inc. (VSTA) Sees AV-101 as Potential Breakthrough Drug for Major Depressive Disorder Potential to Address Major U.S. and Global Need It’s one of the single most sought-after...read more
0 stars

VistaGen Therapeutics, Inc. (VSTA) Receives Notice of Allowa

VistaGen Therapeutics, Inc. (VSTA) Receives Notice of Allowance for Stem Cell Technology Today before the opening bell, VistaGen Therapeutics announced its reception of a Notice of Allowance from the...read more
0 stars

VistaGen Therapeutics, Inc. (VSTA) Provides Reverse Stock Sp

VistaGen Therapeutics, Inc. (VSTA) Provides Reverse Stock Split FAQs Last week, VistaGen Therapeutics implemented a 1-for-20 reverse split of its common stock. As a result, the number of shares of...read more
0 stars

VistaGen Therapeutics, Inc. (VSTA) Announces New Agreement

VistaGen Therapeutics, Inc. (VSTA) Announces New Agreement with Largest Shareholder In an 8-K filed with the SEC today, VistaGen Therapeutics announced that Platinum Long Term Growth VII, LLC, the...read more
0 stars

Millions in Grant Funding Provide Foundation of Opportunity

Millions in Grant Funding Provide Foundation of Opportunity for VistaGen Therapeutics, Inc. (VSTA) The National Institute of Health aims to supports biomedical science and behavioral research through...read more
0 stars

VistaGen Therapeutics, Inc. (VSTA) at Forefront of Stem Cel

VistaGen Therapeutics, Inc. (VSTA) at Forefront of Stem Cell Technology for Drug Rescue, Regenerative Medicine, Small Molecule Drugs VistaGen Therapeutics stands at the forefront today of the rapidly...read more
0 stars

VistaGen Therapeutics, Inc. (VSTA) Drug Rescue Model Resusc

VistaGen Therapeutics, Inc. (VSTA) Drug Rescue Model Resuscitates Failed Drug Candidates VistaGen Therapeutics is focused on drug rescue and regenerative medicine, applying its pluripotent stem cell...read more
0 stars

VistaGen Therapeutics, Inc. (VSTA) Employs a Unique Drug Re

VistaGen Therapeutics, Inc. (VSTA) Employs a Unique Drug Rescue Model VistaGen Therapeutics is a biotechnology company mainly focusing on human pluripotent stem cell (hPSC) technology for drug rescue...read more
0 stars

VistaGen Therapeutics, Inc. (VSTA) Expands IP Portfolio, Aw

VistaGen Therapeutics, Inc. (VSTA) Expands IP Portfolio, Awarded Canadian Patent Coverage VistaGen Therapeutics, a biotech company using proprietary pluripotent stem cell technology for drug rescue...read more
0 stars

VistaGen Therapeutics, Inc. (VSTA) Stands to Reverse Tremend

VistaGen Therapeutics, Inc. (VSTA) Stands to Reverse Tremendous Costs of Drug Failure with Pluripotent Stem Cell Technology For 16 years, California-based VistaGen Therapeutics has worked with key...read more
0 stars

VistaGen, Inc. (VSTA) Aims to Breathe Life into Shelved, Hig

VistaGen, Inc. (VSTA) Aims to Breathe Life into Shelved, High Potential Drug Candidates and Revitalize Drug Development VistaGen Therapeutics is a stem cell company which centers its attention on...read more
0 stars

VistaGen, Inc. (VSTA) Aims to Breathe Life into Shelved, Hig

VistaGen, Inc. (VSTA) Aims to Breathe Life into Shelved, High Potential Drug Candidates and Revitalize Drug Development VistaGen is a biotech company applying pluripotent stem cell technology for...read more
0 stars

VistaGen Therapeutics, Inc. (VSTA) Joins HESI Cardiac Safety

VistaGen Therapeutics, Inc. (VSTA) Joins HESI Cardiac Safety Committee, Sees Collaborative Benefits VistaGen Therapeutics, a biotechnology company applying pluripotent stem cell technology for drug...read more
0 stars

VistaGen Therapeutics, Inc. (VSTA) Human Pluripotent Stem Ce

VistaGen Therapeutics, Inc. (VSTA) Human Pluripotent Stem Cell-Based Bioassay Technology Stands to Revolutionize $51B+ Drug R&D Space VistaGen Therapeutics stands at the forefront of the biotech...read more
0 stars

National Institute of Health’s Focus on Drug Rescue to Benef

National Institute of Health’s Focus on Drug Rescue to Benefit VistaGen Therapeutics (VSTA) VistaGen Therapeutics is a 16-year-old biotechnology company that uses human pluripotent stem cell (hPSC...read more
0 stars

VistaGen Therapeutics, Inc. (VSTA) Receives Notice of Allowa

VistaGen Therapeutics, Inc. (VSTA) Receives Notice of Allowance for U.S. Patent Expanding Stem Cell Technology Platform for Drug Rescue and Regenerative Medicine Today, VistaGen Therapeutics...read more